Gsa Capital Partners LLP Cara Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.19 Billion
- Q1 2024
A detailed history of Gsa Capital Partners LLP transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 45,268 shares of CARA stock, worth $14,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,268
Previous 225,162
79.9%
Holding current value
$14,938
Previous $166,000
75.3%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CARA
# of Institutions
102Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$1.13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.48MShares$818,8150.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$598,9690.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$561,6960.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$513,5620.01% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $17.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...